ORGANIZATIONAL AND PHARMACEUTICAL FOUNDATIONS FOR IMPROVING MEDICINE STORAGE AND DISTRIBUTION PROCESSES IN COMMUNITY PHARMACIES

Authors

  • Yoʻldasheva Xurriyat Author

Keywords:

community pharmacy, pharmaceutical management, medicine storage, pharmaceutical distribution, Good Pharmacy Practice, Good Storage Practice, Good Distribution Practice, pharmaceutical logistics, quality management, digital inventory management, pharmaceutical safety.

Abstract

This article examines the theoretical and practical aspects of improving the organization of medicine storage, receipt, inventory management, and dispensing processes in community pharmacies. Particular attention is paid to establishing appropriate organizational conditions for maintaining the quality, safety, and effectiveness of pharmaceutical products, managing storage facilities, monitoring temperature and humidity, controlling expiration dates, and maintaining pharmaceutical documentation. The importance of Good Pharmacy Practice (GPP), Good Storage Practice (GSP), and Good Distribution Practice (GDP) principles in modern pharmacy management is also discussed. The study is based on a theoretical analysis of scientific literature, international pharmaceutical guidelines, and organizational management approaches. The findings of the literature analysis highlight the interrelationship between risk-based quality management, digital inventory systems, professional responsibility, and standardized operating procedures. An integrated organizational and pharmaceutical management model is proposed to improve the efficiency and reliability of medicine handling processes in community pharmacies. The proposed approach emphasizes the importance of systematic monitoring, appropriate storage conditions, effective inventory control, and continuous professional development in ensuring pharmaceutical safety and improving the quality of pharmacy services.

References

1.World Health Organization. (2020). Good storage and distribution practices for medical products. WHO Technical Report Series, No. 1025, Annex 7. Geneva: WHO.

2.World Health Organization & International Pharmaceutical Federation. (2011). Joint FIP/WHO guidelines on good pharmacy practice: Standards for quality pharmacy services. WHO Technical Report Series, No. 961, Annex 8. Geneva: WHO.

3.European Commission. (2013). Guidelines of 5 November 2013 on Good Distribution Practice of medicinal products for human use. Official Journal of the European Union, C 343, 1–14.

4.International Council for Harmonisation. (2023). ICH Q9(R1): Quality Risk Management. Geneva: ICH.

5.Management Sciences for Health. (2012). MDS-3: Managing Access to Medicines and Health Technologies. Arlington, VA: Management Sciences for Health.

6.World Health Organization. (2011). WHO good practices for pharmaceutical quality control laboratories. WHO Technical Report Series, No. 957, Annex 1. Geneva: WHO.

7.World Health Organization. (2003). Guide to good storage practices for pharmaceuticals. WHO Technical Report Series, No. 908, Annex 9. Geneva: WHO.

8.International Organization for Standardization. (2015). ISO 9001:2015 — Quality Management Systems: Requirements. Geneva: ISO.

9.World Health Organization. (2017). WHO Global Surveillance and Monitoring System for Substandard and Falsified Medical Products. Geneva: WHO.

10.International Pharmaceutical Federation. (2020). FIP Development Goals: Transforming Global Pharmacy. The Hague: FIP.

Downloads

Published

2026-10-15